Featured
Read our handpicked blogs, curated for you.
|
The Enforcement Horizon: August 2, 2026The industry consensus is dominated by the EU AI Act. As of mid-2026, AI systems…
|
The 2026 Industry Consensus: From Policies to EnforcementThe prevailing consensus among global Tier-1 banks is the…
|
The 2026 Industry Consensus: Unified Systems OrchestrationThe prevailing consensus in 2026 is that "more models…
Recent releases
|
Pharma CRM Blind Spots: Why HCP Journeys Need More Than a Rep Log
Pharma CRM has long been the backbone of sales operations in Indian pharma. For years, it has served as the digital logbook of rep interactions, who visited which doctor, when, and with what message…
|
Pharma Content Engines Why PowerPoint and Agencies Are No Longer Enough
Every pharma CMO knows the routine. A brand team needs new content. An agency is briefed, a PowerPoint deck is created, and then the MLR process drags for weeks. By the time it’s approved, the…
|
Next Best Action Artificial Intelligence in Pharma Separating Hype from Real Outcomes
Everywhere you turn, someone is pitching artificial intelligence in pharma as the future. Vendors promise predictive insights, automated engagement, and “next best action” recommendations that will…
|
The Pharma ROI Black Hole Why Spends Crores Without Knowing What Works
The problem no one wants to admit is that every year, Indian pharma companies spend crores on marketing- reps, conferences, digital campaigns, agencies. Yet when boards ask the simplest question-…
